Actively Recruiting

Age: 18Years +
All Genders
NCT05554224

Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease

Led by Institut Investigacio Sanitaria Pere Virgili · Updated on 2024-11-13

1104

Participants Needed

1

Research Sites

1070 weeks

Total Duration

On this page

Sponsors

I

Institut Investigacio Sanitaria Pere Virgili

Lead Sponsor

H

Hospital Universitari Sant Joan

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators seek to analyze the samples provided by patients with obesity-associated fatty liver disease at the multi-omics level and to integrate the results with clinical information, genotypic variants, and factors influencing inter-organ crosstalk. The main aim is to improve the interpretation of fatty liver disease associated with obesity and diabetes by developing predictive models built with algorithms from artificial intelligence. The challenge is to decipher the flow of information by exploring contributing factors, proximate causes of regulatory defects, and maladaptive responses that may promote therapeutic approaches.

CONDITIONS

Official Title

Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Body mass index greater or equal to 40 kg/m^2.
  • Body mass index between 35 and 40 kg/m^2 with high-risk comorbidities (diagnosis or treatment for hypertension, dyslipidemia, or type 2 diabetes mellitus).
  • Positive psychiatric evaluation.
  • Age greater or equal to 18 years old.
Not Eligible

You will not qualify if you...

  • Legal or illegal drug consumption, including alcohol.
  • Diagnosis of Hepatitis.
  • Current cancer diagnosis or treatment.
  • Clinical or analytical evidence of severe illness.
  • Clinical or analytical evidence of chronic or acute inflammation.
  • Clinical or analytical evidence of infectious diseases.
  • Clinical or analytical evidence of terminal illness.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital Universitari Sant Joan

Reus, Tarragona, Spain, 43204

Actively Recruiting

Loading map...

Research Team

J

Jorge Joven, Professor

CONTACT

H

Helena Castañé, MSc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here